• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Mechanistic Episodes on SARS-CoV-2-Mediated Neurological Manifestations and Their Possible Therapeutic Interventions
J Environ Pathol Toxicol Oncol. 2022;41(1):85-98. doi: 10.1615/JEnvironPatholToxicolOncol.2021040128.ABSTRACTRecently, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been critically recognized and spread rapidly on this planet. Considerable recognition of SARS-CoV-2 has been known with a range of viruses that are more capable to cause diseases in avian and mammals including humans. The virus was found as a main culprit for major defects in respiratory system and thereby caused severe acute respiratory syndrome disease. This has led to depict the mortality in human population. Nevertheless...
Source: Journal of Environmental Pathology, Toxicology and Oncology - April 4, 2022 Category: Environmental Health Authors: Sobia Nida Hemalatha Srinivisan Ashok Kumar Pandurangan Mohammad Waseem Source Type: research

Clinical characteristics of patients with acute ischemic stroke previously vaccinated against COVID-19
The aim of this study was to examine the clinical characteristics of patients with acute ischemic stroke which were previously vaccinated against Coronavirus Disease 2019 (COVID-19) and determine whether the vaccine had impact on outcome.
Source: Journal of Stroke and Cerebrovascular Diseases - April 3, 2022 Category: Neurology Authors: Marija Stamenkovi ć, Ljiljana Radmilo, Mirjana Jovićević, Tamara Rabi-Žikić, Marija Žarkov, Svetlana Ružička-Kaloci, Svetlana Simić, Aleksandar Stamenković, Željko Živanović Source Type: research

Early-Onset Myasthenia Gravis Following COVID-19 Vaccination
J Korean Med Sci. 2022 Mar 14;37(10):e50. doi: 10.3346/jkms.2022.37.e50.ABSTRACTAs coronavirus disease 2019 (COVID-19) has spread worldwide, the rate of COVID-19 vaccination uptake is encouraging. Neurological complications associated with COVID-19 vaccines such as stroke, Guillain-Barré syndrome, and Bell's palsy have been reported. Recently, late-onset myasthenia gravis (MG) following COVID-19 vaccination has been reported. To date, however, there has been no evidence of increased risk of early-onset MG following COVID-19. Here, we report a case of a patient with new-onset MG that arose after receiving a COVID-19 vaccin...
Source: J Korean Med Sci - March 15, 2022 Category: General Medicine Authors: Myung Ah Lee Chonghwee Lee Jung Hyun Park Jung Hwan Lee Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13